At ECR 2026 in Vienna, Guerbet will mark its 100th anniversary while presenting developments across contrast-enhanced MRI, real-world evidence, and international collaboration
Bayer has released late-breaking results from the QUANTI Pediatric study, showing that its investigational low-dose MRI contrast agent gadoquatrane met all primary and secondary endpoints in children.
Nottingham University Hospitals NHS Trust (NUH) has become the first site in the UK to install a photon-counting CT scanner with integrated laser-guided intervention.
This website uses cookies to give our readers the best website experience. Please refer to our privacy policy to find out how we use cookies and how you can edit your preferences.